We are looking for a talented and open-minded student who is interested in doing the research for his/her master's thesis in Computational Chemistry in the Medicinal Chemistry Department at BI's Oncology research site in Vienna.
Duties & Responsibilities
- Supporting to develop and deploy computational methods that facilitate or support structure-based compound design by means of quantum chemistry and/or knowledge mining of structural databases
- Contributing to fundamental scientific aspects which are aimed at increasing the accuracy and robustness of theory-driven and knowledge-based drug design
- Master's degree students in Computational Chemistry or related field (Theoretical Chemistry, Bio-/Chemoinformatics, Quantum chemistry, Scientific Software Design, Software Development)
- Excellent programming skills in a commonly used programming or scripting language (e.g. Python, Perl, Java, C++) are essential, and experience with SVL is a plus
- Good knowledge of a molecular modelling software package (e.g. MOE, Maestro) is preferred
- A solid understanding of chemistry and the drug discovery process is crucial, with a preference for the focus being on quantum chemistry and/or structural chemistry
- Full command of German and/or English
- Good communication and team-work skills
Our CultureBoehringer Ingelheim is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 50,000 employees. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. In 2015, Boehringer Ingelheim achieved net sales of about 14.8 billion euros. R&D expenditure corresponds to 20.3 per cent of net sales.
Boehringer Ingelheim is an equal opportunity employer who takes pride in maintaining a diverse and inclusive workplace. We embrace all aspects of diversity and inclusion which benefit our employees, patients and communities.